Physician profile
Kenneth M Ripp
NPI 1245312537
$239.00
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.67 · 2020: $27.99 · 2021: $78.46 · 2022: $12.48 · 2023: $59.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $59.40 | 2023 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.74 | 2021 | |
| Astellas Pharma US INC | $27.08 | 2020-2021 | |
| Pfizer INC. | $25.21 | 2019-2021 | |
| Novo Nordisk INC | $24.20 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $14.01 | 2021 | |
| Hologic Sales and Service, LLC | $13.54 | 2019 | |
| Allergan, INC. | $12.72 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.19 | 2019 | |
| Glaxosmithkline, LLC. | $12.07 | 2020 | |
| Sanofi Pasteur INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Ripp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.